Moreover, CRC induction in murine elevated Act-A and inhibited Smad4 proteins, whilst hesperidin treatment decreased the tumour numbers and increased the levels of Act-A and Smad4 in malignant tissues [7, 33]. The gene discussed is ACTA1; the disease is colorectal carcinoma.